These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 964292)

  • 1. Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. II. Relationship to its effect on blood pressure and plasma renin activity.
    Collste P; Haglund K; Frisk-Holmberg M; Orme ML; Rawlins MD; Ostman J
    Eur J Clin Pharmacol; 1976 Jun; 10(2):89-95. PubMed ID: 964292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. I. Relationship between plasma concentration and adrenergic beta-receptor blockade.
    Collste P; Haglund K; Frisk-Holmberg M; Rawlins MD
    Eur J Clin Pharmacol; 1976 Jun; 10(2):85-8. PubMed ID: 9292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma renin concentration in essential hypertension during beta-adrenergic blockade and vasodilator therapy.
    Pedersen EB; Kornerup HJ
    Eur J Clin Pharmacol; 1977 Oct; 12(2):93-6. PubMed ID: 923630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between plasma aldosterone concentration and plasma potassium in patients with essential hypertension during alprenolol treatment.
    Pedersen EB; Kornerup HJ
    Acta Med Scand; 1976; 200(4):263-7. PubMed ID: 983793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of alprenolol and hydralazine on plasma renin concentration in patients with arterial hypertension.
    Pedersen EB; Kornerup HJ
    Acta Med Scand; 1975 Nov; 198(5):379-83. PubMed ID: 1199814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of alprenolol on blood pressure and plasma renin activity in hypertensive patients.
    Castenfors J; Johnsson H; Orö L
    Acta Med Scand; 1973 Mar; 193(3):189-95. PubMed ID: 4571479
    [No Abstract]   [Full Text] [Related]  

  • 7. Twice-daily pindolol and alprenolol in essential hypertension of moderate severity.
    Hartikainen M; Heikkilä J
    Ann Clin Res; 1976 Apr; 8(2):85-92. PubMed ID: 779590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dose ranging study of atenolol in hypertension: fall in blood pressure and plasma renin activity, beta-blockade and steady-state pharmacokinetics.
    Ishizaki T; Oyama Y; Suganuma T; Sasaki T; Nakaya H; Shibuya T; Sato T
    Br J Clin Pharmacol; 1983 Jul; 16(1):17-25. PubMed ID: 6349668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased plasma concentrations and clinical effects of alprenolol during combined treatment with pentobarbitone in hypertension.
    Seideman P; Borg KO; Haglund K; Von Bahr C
    Br J Clin Pharmacol; 1987 Mar; 23(3):267-71. PubMed ID: 3567041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo-controlled, double-blind clinical trial of alprenolol in African hypertensive patients.
    Salako LA; Falase AO; Aderounmu AF
    Curr Med Res Opin; 1979; 6(5):358-63. PubMed ID: 396111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of beta-adrenergic blockade on patterns of urinary sodium excretion, blood pressure and plasma renin activity in patients with essential and renovascular hypertension.
    Salvetti A; Sassano P; Poli L; Arzilli F; Pedrinelli R
    Eur J Clin Invest; 1977 Oct; 7(5):331-6. PubMed ID: 411663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course of blood pressure, pulse rate, plasma renin and metoprolol during treatment of hypertensive patients.
    Haglund K; Collste P
    Eur J Clin Pharmacol; 1980 May; 17(5):321-8. PubMed ID: 6998708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels and effects of metoprolol on blood pressure, adrenergic beta receptor blockade, and plasma renin activity in essential hypertension.
    von Bahr C; Collste P; Frisk-Holmberg M; Haglund K; Jorfelt L; Orme M; Ostman J; Sjoqvist F
    Clin Pharmacol Ther; 1976 Aug; 20(2):130-7. PubMed ID: 7373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of alprenolol on hemodynamic and metabolic responses to prolonged exercise in subjects with hypertension.
    Frisk-Holmberg M; Jorfeldt L; Juhlin-Dannfeldt A
    Clin Pharmacol Ther; 1977 Jun; 21(6):675-84. PubMed ID: 324693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind comparison of metoprolol, alprenolol, and oxprenolol in hypertension.
    Tuomilehto J; Nissinen A
    Eur J Clin Pharmacol; 1979; 16(6):369-74. PubMed ID: 393518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A within-patient comparison of alprenolol and propranolol in hypertension.
    Berglund G; Hansson L
    Acta Med Scand; 1973 Jun; 193(6):547-50. PubMed ID: 4721964
    [No Abstract]   [Full Text] [Related]  

  • 18. Glomerular filtration rate and renal plasma flow in patients with essential hypertension before and after treatment with alprenolol.
    Pedersen EB
    Acta Med Scand; 1975 Nov; 198(5):365-71. PubMed ID: 1199812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of pindolol on plasma renin activity and blood pressure in hypertensive patients.
    Lancaster R; Goodwin TJ; Peart WS
    Br J Clin Pharmacol; 1976 Jun; 3(3):453-60. PubMed ID: 973972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prazosin first dose phenomenon during combined treatment with a beta-adrenoceptor blocker in hypertensive patients.
    Seideman P; Grahnén A; Haglund K; Lindström B; Von Bahr C
    Br J Clin Pharmacol; 1982 Jun; 13(6):865-70. PubMed ID: 7093116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.